# Physical Activity and Fatigue in Early Multiple Sclerosis (MS)

> **NCT00882453** · — · COMPLETED · sponsor: **Bayer** · enrollment: 1739 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon beta-1b (Betaseron, BAY86-5046)

## Key facts

- **NCT ID:** NCT00882453
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 1739 (ACTUAL)
- **Last updated:** 2012-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00882453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00882453, "Physical Activity and Fatigue in Early Multiple Sclerosis (MS)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00882453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*